Recently Funded Biotech Companies 2026

PDE4B inhibitor for inflammatory and fibrotic lung disease

AI and robotics enabled drug development, starting with clinical bioanalysis.

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Clinical-stage biotech advancing a Phase 2 COPD therapy.

Claris Bio is a privately-held company developing a topical formulation of innovative therapies f...

Bioinformatics-led company using whole-genome data and proprietary analytics to deliver curated, ...

Clinical-stage company transforming gout treatment with next-generation URAT1 inhibitor

AI biopharma drug discovery startup

Developer of bio-based, waterless dyeing technologies.

Reflux disease therapeutics platform

Off-the-shelf engineered CAR-T cell therapy for solid tumors

AI-powered drug discovery for neurological diseases

Cancer immunotherapy platform

Biotech company developing next-generation cell and gene therapies for cancer.

Neko Health focuses on preventive healthcare through advanced scanning technology.

AI-native engine for drug research and development.

Cancer immunotherapy platform (formerly EG 427)

AI-powered data platform for chronic disease research

Biotech company focused on respiratory disease treatment.

Mitochondrial disease therapy platform for clinical development

Clinical-stage biotechnology company developing precision therapies for autoimmune diseases.

Melbourne university brain-chip technology spinout.

Pain management pharmaceutical company

Biotechnology startup launching with pre-seed funding.